Sublingual misoprostol versus intravenous oxytocin in prevention of post-partum hemorrhage.

about

Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in Uganda: a double-blind randomized non-inferiority trial Third Stage of Labor and Acupuncture Acupuncture for retained placenta: a retrospective case series.

P2860

Q21144590-E635E85E-6C0A-4AAB-8091-0E10454E91AA Q26866389-E7425144-1E8E-4825-9172-443F070E866B Q47818792-4C2FD293-E3E8-4695-BDAD-443191E87F78

P2860

Sublingual misoprostol versus intravenous oxytocin in prevention of post-partum hemorrhage.

Item

http://www.wikidata.org/entity/Q40234311

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Sublingual misoprostol versus ...... ion of post-partum hemorrhage.

@en

type

Item

label

Sublingual misoprostol versus ...... ion of post-partum hemorrhage.

@en

prefLabel

Sublingual misoprostol versus ...... ion of post-partum hemorrhage.

@en

P1476

Sublingual misoprostol versus ...... ion of post-partum hemorrhage.

@en

P2093

Bela Makhija

http://www.w3.org/2001/XMLSchema#string

Renu Tewatia

http://www.w3.org/2001/XMLSchema#string

Shikha Rani

http://www.w3.org/2001/XMLSchema#string

Usha Srivastav

http://www.w3.org/2001/XMLSchema#string

P2860

Where do poor women in developing countries give birth? A multi-country analysis of demographic and health survey data

Misoprostol for postpartum hemorrhage prevention at home birth: an integrative review of global implementation experience to date

Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects.

Epidemiology of postpartum haemorrhage: a systematic review.

Misoprostol for the prevention and treatment of postpartum hemorrhage.

Dose and duration of oxytocin to prevent postpartum hemorrhage: a review.

Active management of the third stage of labour with and without controlled cord traction: a randomised, controlled, non-inferiority trial.

Maternal mortality: one death every 7 min.

Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in low-risk women.

The effect of misoprostol on postpartum contractions: a randomised comparison of three sublingual doses.

P2888

s00404-013-3026-2

P304

739-742

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00404-013-3026-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

289

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24045979

http://www.w3.org/2001/XMLSchema#string

P921

oxytocin

maternal health

Sublingual misoprostol versus intravenous oxytocin in prevention of post-partum hemorrhage.

about

P2860

P2860

Sublingual misoprostol versus intravenous oxytocin in prevention of post-partum hemorrhage.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921